Adding to the evidence or to the confusion: dual antithrombotic therapy in chronic coronary syndrome and atrial fibrillation

Atrial fibrillation (AF) is the most common arrhythmia in the world with the lifetime risk estimated to be 1/3 in men and women over the age of 50 years.1 Cardiovascular disease, like misfortune, does not come singly in most cases. Coronary artery disease (CAD) with the chronic coronary syndrome (CCS) or acute coronary syndrome (ACS) is a common comorbid condition. Management of patients with AF with a comprehensive treatment of risk factors and...